(Q39397885)

English

Reaching a consensus on management practices and vaccine development targets for mitigation of infectious diarrhoea among deployed US military forces

scientific article published on 18 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Reaching a consensus on management practices and vaccine development targets for mitigation of infectious diarrhoea among deployed US military forces (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

author name string

Mark S Riddle

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

David R Tribble

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

18 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Journal of Evaluation in Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

266-274

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

The epidemiology of self-reported diarrhea in operations Iraqi freedom and enduring freedom

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Diarrheal illness among deployed U.S. military personnel during Operation Bright Star 2001--Egypt

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Research guidelines for the Delphi survey technique.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

The Delphi technique

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Self-reported description of diarrhea among military populations in operations Iraqi Freedom and Enduring Freedom

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

A review of vaccine research and development: human enteric infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Vaccines against diarrheal diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Campylobacter vaccine development:a key to controlling enteric diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Vaccines against Campylobacter jejuni

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Human susceptibility and resistance to Norwalk virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Yellow fever and Japanese encephalitis vaccines: indications and complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Travel-related vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Adverse reactions to Japanese encephalitis vaccine in travellers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Qualitative Research: Consensus methods for medical and health services research

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Modified Delphi survey for decision analysis for prophylaxis of post-radiation osteonecrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Economic evaluation in schistosomiasis: using the Delphi technique to assess effectiveness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2007.00848.X

21 January 2018

Identifiers

10.1111/J.1365-2753.2007.00848.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39397885&oldid=1825339253"